Prognostic significance of PAI-1 and uPA in cytosolic extracts obtained from node-positive breast cancer patients (Q73297547)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9131271%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

title

Prognostic significance of PAI-1 and uPA in cytosolic extracts obtained from node-positive breast cancer patients (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9131271%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

author name string

J Grøndahl-Hansen

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9131271%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

S G Hilsenbeck

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9131271%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

I J Christensen

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9131271%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

G M Clark

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9131271%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

C K Osborne

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9131271%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

N Brünner

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9131271%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

publication date

1 April 1997

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9131271%20AND%20SRC:MED&resulttype=core&format=json

Breast Cancer Research and Treatment

2 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9131271%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

volume

43

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9131271%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9131271%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

page(s)

153-163

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9131271%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1023/a:1005744914124

2 November 2019

exact match

0 references

cites work

Plasminogen activator inhibitors: hormonally regulated serpins

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1005744914124

7 January 2021

Expression of human recombinant plasminogen activators enhances invasion and experimental metastasis of H-ras-transformed NIH 3T3 cells

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1005744914124

7 January 2021

Immunohistochemical localization of the plasminogen activator inhibitor-1 in breast cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1005744914124

7 January 2021

Plasminogen-activator inhibitor type 1 is a potent natural inhibitor of extracellular matrix degradation by fibrosarcoma and colon carcinoma cells

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1005744914124

7 January 2021

Prediction of relapse or survival in patients with node-negative breast cancer by DNA flow cytometry

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1005744914124

7 January 2021

Urokinase-plasminogen activator, a marker for aggressive breast carcinomas. Preliminary report

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1005744914124

7 January 2021

The receptor for urokinase type plasminogen activator polarizes expression of the protease to the leading edge of migrating monocytes and promotes degradation of enzyme inhibitor complexes

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1005744914124

7 January 2021

Plasminogen activator inhibitor-1 and prognosis in primary breast cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1005744914124

7 January 2021

Clinical relevance of the urokinase-type and tissue-type plasminogen activators and of their type 1 inhibitor in breast cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1005744914124

7 January 2021

Tumor invasion through the human amniotic membrane: requirement for a proteinase cascade

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1005744914124

7 January 2021

Purification of zymogen to plasminogen activator from human glioblastoma cells by affinity chromatography with monoclonal antibody.

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1005744914124

7 January 2021

In vivo invasion of modified chorioallantoic membrane by tumor cells: the role of cell surface-bound urokinase

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1005744914124

7 January 2021

Antibodies to plasminogen activator inhibit human tumor metastasis

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1005744914124

7 January 2021

Complementation between urokinase-producing and receptor-producing cells in extracellular matrix degradation

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1005744914124

7 January 2021

Enzyme-linked immunosorbent assay of urokinase-type plasminogen activator (uPA) in cytosolic extracts of human breast cancer tissue

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1005744914124

7 January 2021